The R&D department is composed of a multidisciplinary team of top-level scientists who are focused on the development of new innovative products and technologies.
This highly skilled research organization has built a significant intellectual property and continuously improved the performance of ORGÉV products through internal clinical studies and discovery research projects, permanent review of medical literature, and constant and close contact with the medical world.
To ensure a strong pipeline of new products, ORGÉV researchers work also closely through research collaborations with laboratories of prestigious universities and institutes in identifying future biomolecules and designing new formulations and bioprocesses useful in the prevention and treatment of aging-related diseases, disorders, and disabilities.
Every day, our researchers are studying the various damages occurring in connective tissue and induced by time, environment (sunlight, pollution etc.), daily stress and mechanical constraints, enabling ORGÉV to continue to develop advanced solutions for the medical market, in line with practitioners’ current expectations and future needs.